Annual Net Income:
-$372.18M+$71.86M(+16.18%)Summary
- As of today, IOVA annual net profit is -$372.18 million, with the most recent change of +$71.86 million (+16.18%) on December 31, 2024.
- During the last 3 years, IOVA annual net income has fallen by -$29.93 million (-8.74%).
- IOVA annual net income is now -2355450.63% below its all-time high of -$15.80 thousand, reached on December 31, 2009.
Performance
IOVA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$111.66M+$4.50M(+3.88%)Summary
- As of today, IOVA quarterly net profit is -$111.66 million, with the most recent change of +$4.50 million (+3.88%) on June 30, 2025.
- Over the past year, IOVA quarterly net income has dropped by -$14.56 million (-14.99%).
- IOVA quarterly net income is now -3321.34% below its all-time high of $3.47 million, reached on December 31, 2012.
Performance
IOVA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$389.92M-$14.56M(-3.88%)Summary
- As of today, IOVA TTM net profit is -$389.92 million, with the most recent change of -$14.56 million (-3.88%) on June 30, 2025.
- Over the past year, IOVA TTM net income has increased by +$50.30 million (+11.43%).
- IOVA TTM net income is now -27588.26% below its all-time high of $1.42 million, reached on March 31, 2013.
Performance
IOVA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
IOVA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +16.2% | -15.0% | +11.4% |
| 3Y3 Years | -8.7% | -12.4% | -3.6% |
| 5Y5 Years | -88.4% | -77.2% | -53.1% |
IOVA Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -8.7% | +16.2% | -42.1% | +4.1% | -4.8% | +13.3% |
| 5Y | 5-Year | -88.4% | +16.2% | -90.6% | +4.1% | -53.1% | +13.3% |
| All-Time | All-Time | >-9999.0% | +16.2% | -3321.3% | +4.1% | >-9999.0% | +13.3% |
IOVA Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$111.66M(+3.9%) | -$389.92M(-3.9%) |
| Mar 2025 | - | -$116.16M(-47.9%) | -$375.36M(-0.9%) |
| Dec 2024 | -$372.18M(+16.2%) | -$78.56M(+6.0%) | -$372.18M(+9.2%) |
| Sep 2024 | - | -$83.54M(+14.0%) | -$410.00M(+6.9%) |
| Jun 2024 | - | -$97.10M(+14.1%) | -$440.22M(+2.1%) |
| Mar 2024 | - | -$112.98M(+2.9%) | -$449.64M(-1.3%) |
| Dec 2023 | -$444.04M(-12.2%) | -$116.38M(-2.3%) | -$444.04M(-2.6%) |
| Sep 2023 | - | -$113.76M(-6.8%) | -$432.98M(-3.4%) |
| Jun 2023 | - | -$106.53M(+0.8%) | -$418.83M(-1.7%) |
| Mar 2023 | - | -$107.37M(-1.9%) | -$411.66M(-4.0%) |
| Dec 2022 | -$395.89M(-15.7%) | -$105.32M(-5.7%) | -$395.89M(-1.5%) |
| Sep 2022 | - | -$99.62M(-0.3%) | -$389.90M(-3.6%) |
| Jun 2022 | - | -$99.35M(-8.5%) | -$376.41M(-5.0%) |
| Mar 2022 | - | -$91.61M(+7.8%) | -$358.41M(-4.7%) |
| Dec 2021 | -$342.25M(-31.8%) | -$99.33M(-15.3%) | -$342.25M(-9.9%) |
| Sep 2021 | - | -$86.12M(-5.9%) | -$311.32M(-9.7%) |
| Jun 2021 | - | -$81.35M(-7.8%) | -$283.77M(-6.9%) |
| Mar 2021 | - | -$75.45M(-10.3%) | -$265.44M(-2.3%) |
| Dec 2020 | -$259.58M(-31.4%) | -$68.40M(-16.8%) | -$259.58M(-1.9%) |
| Sep 2020 | - | -$58.57M(+7.1%) | -$254.75M(-3.7%) |
| Jun 2020 | - | -$63.02M(+9.5%) | -$245.67M(-6.7%) |
| Mar 2020 | - | -$69.59M(-9.5%) | -$230.20M(-16.5%) |
| Dec 2019 | -$197.56M(-59.9%) | -$63.57M(-28.5%) | -$197.56M(-18.6%) |
| Sep 2019 | - | -$49.49M(-4.1%) | -$166.56M(-10.4%) |
| Jun 2019 | - | -$47.55M(-28.7%) | -$150.91M(-12.6%) |
| Mar 2019 | - | -$36.95M(-13.4%) | -$134.01M(-8.4%) |
| Dec 2018 | -$123.58M(-34.2%) | -$32.58M(+3.7%) | -$123.58M(-5.8%) |
| Sep 2018 | - | -$33.83M(-10.3%) | -$116.86M(-11.1%) |
| Jun 2018 | - | -$30.66M(-15.6%) | -$105.18M(-7.4%) |
| Mar 2018 | - | -$26.52M(-2.6%) | -$97.89M(-6.3%) |
| Dec 2017 | -$92.06M(-74.1%) | -$25.85M(-16.7%) | -$92.06M(-12.4%) |
| Sep 2017 | - | -$22.15M(+5.3%) | -$81.90M(-4.3%) |
| Jun 2017 | - | -$23.38M(-13.0%) | -$78.51M(-17.7%) |
| Mar 2017 | - | -$20.68M(-31.8%) | -$66.69M(-26.1%) |
| Dec 2016 | -$52.89M | -$15.69M(+16.4%) | -$52.89M(-14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$18.76M(-62.2%) | -$46.16M(-31.7%) |
| Jun 2016 | - | -$11.56M(-68.0%) | -$35.04M(-17.4%) |
| Mar 2016 | - | -$6.88M(+23.1%) | -$29.84M(-5.6%) |
| Dec 2015 | -$27.66M(-129.8%) | -$8.96M(-17.3%) | -$28.26M(-16.9%) |
| Sep 2015 | - | -$7.63M(-19.9%) | -$24.17M(-25.0%) |
| Jun 2015 | - | -$6.37M(-20.2%) | -$19.33M(-28.2%) |
| Mar 2015 | - | -$5.30M(-8.9%) | -$15.07M(-25.2%) |
| Dec 2014 | -$12.03M(+52.6%) | -$4.87M(-73.9%) | -$12.03M(+35.5%) |
| Sep 2014 | - | -$2.80M(-32.6%) | -$18.66M(+26.2%) |
| Jun 2014 | - | -$2.11M(+6.6%) | -$25.28M(+5.0%) |
| Mar 2014 | - | -$2.26M(+80.3%) | -$26.59M(-4.8%) |
| Dec 2013 | -$25.38M(-667.4%) | -$11.50M(-22.2%) | -$25.38M(-143.6%) |
| Sep 2013 | - | -$9.41M(-174.4%) | -$10.42M(-518.9%) |
| Jun 2013 | - | -$3.43M(-227.7%) | -$1.68M(-218.7%) |
| Mar 2013 | - | -$1.05M(-130.2%) | $1.42M(+142.9%) |
| Dec 2012 | -$3.31M(+87.1%) | $3.47M(+614.3%) | -$3.31M(+78.1%) |
| Sep 2012 | - | -$673.90K(-105.9%) | -$15.13M(+25.4%) |
| Jun 2012 | - | -$327.30K(+94.3%) | -$20.27M(+34.4%) |
| Mar 2012 | - | -$5.77M(+30.9%) | -$30.90M(-20.3%) |
| Dec 2011 | -$25.69M(-1497.9%) | -$8.35M(-43.5%) | -$25.69M(-42.1%) |
| Sep 2011 | - | -$5.82M(+46.9%) | -$18.08M(-39.3%) |
| Jun 2011 | - | -$10.96M(-1842.2%) | -$12.98M(-516.7%) |
| Mar 2011 | - | -$564.30K(+23.9%) | -$2.10M(-30.9%) |
| Dec 2010 | -$1.61M(>-9900.0%) | -$741.90K(-3.9%) | -$1.61M(-85.2%) |
| Sep 2010 | - | -$713.80K(-743.7%) | -$868.40K(-449.3%) |
| Jun 2010 | - | -$84.60K(-25.0%) | -$158.10K(-105.9%) |
| Mar 2010 | - | -$67.70K(-2843.5%) | -$76.80K(-389.2%) |
| Dec 2009 | -$15.80K(+72.3%) | -$2300.00(+34.3%) | -$15.70K(+43.3%) |
| Sep 2009 | - | -$3500.00(-6.1%) | -$27.70K(-3.7%) |
| Jun 2009 | - | -$3300.00(+50.0%) | -$26.70K(+30.5%) |
| Mar 2009 | - | -$6600.00(+53.8%) | -$38.40K(+32.7%) |
| Dec 2008 | -$57.10K | -$14.30K(-472.0%) | -$57.10K(-33.4%) |
| Sep 2008 | - | -$2500.00(+83.3%) | -$42.80K(-6.2%) |
| Jun 2008 | - | -$15.00K(+40.7%) | -$40.30K(-59.3%) |
| Mar 2008 | - | -$25.30K | -$25.30K |
FAQ
- What is Iovance Biotherapeutics, Inc. annual net profit?
- What is the all-time high annual net income for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. annual net income year-on-year change?
- What is Iovance Biotherapeutics, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. quarterly net income year-on-year change?
- What is Iovance Biotherapeutics, Inc. TTM net profit?
- What is the all-time high TTM net income for Iovance Biotherapeutics, Inc.?
- What is Iovance Biotherapeutics, Inc. TTM net income year-on-year change?
What is Iovance Biotherapeutics, Inc. annual net profit?
The current annual net income of IOVA is -$372.18M
What is the all-time high annual net income for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high annual net profit is -$15.80K
What is Iovance Biotherapeutics, Inc. annual net income year-on-year change?
Over the past year, IOVA annual net profit has changed by +$71.86M (+16.18%)
What is Iovance Biotherapeutics, Inc. quarterly net profit?
The current quarterly net income of IOVA is -$111.66M
What is the all-time high quarterly net income for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high quarterly net profit is $3.47M
What is Iovance Biotherapeutics, Inc. quarterly net income year-on-year change?
Over the past year, IOVA quarterly net profit has changed by -$14.56M (-14.99%)
What is Iovance Biotherapeutics, Inc. TTM net profit?
The current TTM net income of IOVA is -$389.92M
What is the all-time high TTM net income for Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. all-time high TTM net profit is $1.42M
What is Iovance Biotherapeutics, Inc. TTM net income year-on-year change?
Over the past year, IOVA TTM net profit has changed by +$50.30M (+11.43%)